top of page
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
HNT962
Head and neck disease tissue array, set 2, non-overlapping with HNT961, 48 cases of inflammatory, benign and malignant tumor tissues of the neck, oranasopharynx, larynx and salivary glands in duplicates with grading and TNM staging data
Price per slide:
$289
Species:
Human
Cases:
48
Cores:
96
Core Size:
1.5 mm
Core Thickness:
4um
Rows:
8
Columns:
12
Format:
Intended Usage:
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in various head and neck tumors.
8
X
12
For illustration purpose only. Actual product may vary.
Notes:
All the tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They can be stored for use at 4C for up to six months from the date of shipment. There may be 5 to 10% of tissue core loss.
Bake at 60C for ~60 minutes before use. If antigen retrieving is needed, it is important to avoid direct-boiling and high pH or high strength antigen retrieving buffer. For availability of complimentary IHC data, please contact us at info@pantomics.com.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | NATURE | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|---|
A01 |  | M | 13 | Head and neck, salivary gland | Inflammation | Benign | ||
A02 |  | M | 63 | Larynx | Inflammation | Benign | ||
A03 |  | M | 41 | Head and neck, nasal cavity | Polyps | Benign | ||
A04 |  | F | 67 | Head and neck, nasal cavity | Polyps | Benign | ||
A05 |  | M | 60 | Head and Neck, left parotid gland | Hemangioma | Benign | ||
A06 |  | M | 40 | Head and neck, left lower mandible | Hemangioma | Benign | ||
A07 |  | M | 8 | Head and Neck, left neck | Neurofibroma | Benign | ||
A08 |  | M | 31 | Face | Neurofibroma | Benign | ||
A09 |  | M | 24 | Head and Neck, left neck | Schwannoma | Benign | ||
A10 |  | F | 30 | Head and Neck, left neck | Schwannoma | Benign | ||
A11 |  | F | 32 | Head and neck, salivary gland | Pleomorphic adenoma | Benign | ||
A12 |  | M | 52 | Head and Neck, left parotid gland | Pleomorphic adenoma | Benign | ||
B01 |  | M | 13 | Head and neck, salivary gland | Inflammation | Benign | ||
B02 |  | M | 63 | Larynx | Inflammation | Benign | ||
B03 |  | M | 41 | Head and neck, nasal cavity | Polyps | Benign | ||
B04 |  | F | 67 | Head and neck, nasal cavity | Polyps | Benign | ||
B05 |  | M | 60 | Head and Neck, left parotid gland | Hemangioma | Benign | ||
B06 |  | M | 40 | Head and neck, left lower mandible | Hemangioma | Benign | ||
B07 |  | M | 8 | Head and Neck, left neck | Neurofibroma | Benign | ||
B08 |  | M | 31 | Face | Neurofibroma | Benign | ||
B09 |  | M | 24 | Head and Neck, left neck | Schwannoma | Benign | ||
B10 |  | F | 30 | Head and Neck, left neck | Schwannoma | Benign | ||
B11 |  | F | 32 | Head and neck, salivary gland | Pleomorphic adenoma | Benign | ||
B12 |  | M | 52 | Head and Neck, left parotid gland | Pleomorphic adenoma | Benign | ||
C01 |  | M | 74 | Larynx | Squamous cell carcinoma | Malignant | I | T3N0M0 |
C02 |  | M | 58 | Larynx | Squamous cell carcinoma | Malignant | I | T2N0M0 |
C03 |  | M | 67 | Larynx | Squamous cell carcinoma | Malignant | I | T2N1M0 |
C04 |  | F | 46 | Head and neck, oral cavity | Squamous cell carcinoma | Malignant | I | T2N2M0 |
C05 |  | M | 63 | Larynx | Squamous cell carcinoma | Malignant | I | T3N1M0 |
C06 |  | M | 42 | Head and neck, oral cavity | Squamous cell carcinoma | Malignant | I | T3N1M0 |
C07 |  | M | 56 | Pharynx | Squamous cell carcinoma | Malignant | I | T3N1M0 |
C08 |  | M | 60 | Larynx | Squamous cell carcinoma | Malignant | I~II | T2N1M0 |
C09 |  | M | 57 | Pharynx | Squamous cell carcinoma | Malignant | I~II | T2N0M0 |
C10 |  | M | 54 | Larynx | Squamous cell carcinoma | Malignant | I~II | T2N0M0 |
C11 |  | M | 55 | Head and neck, oral cavity | Squamous cell carcinoma | Malignant | I~II | T2N1M0 |
C12 |  | M | 65 | Head and neck, oral cavity | Squamous cell carcinoma | Malignant | I~II | T2N0M0 |
D01 |  | M | 74 | Larynx | Squamous cell carcinoma | Malignant | I | T3N0M0 |
D02 |  | M | 58 | Larynx | Squamous cell carcinoma | Malignant | I | T2N0M0 |
D03 |  | M | 67 | Larynx | Squamous cell carcinoma | Malignant | I | T2N1M0 |
D04 |  | F | 46 | Head and neck, oral cavity | Squamous cell carcinoma | Malignant | I | T2N2M0 |
D05 |  | M | 63 | Larynx | Squamous cell carcinoma | Malignant | I | T3N1M0 |
D06 |  | M | 42 | Head and neck, oral cavity | Squamous cell carcinoma | Malignant | I | T3N1M0 |
D07 |  | M | 56 | Pharynx | Squamous cell carcinoma | Malignant | I | T3N1M0 |
D08 |  | M | 60 | Larynx | Squamous cell carcinoma | Malignant | I~II | T2N1M0 |
D09 |  | M | 57 | Pharynx | Squamous cell carcinoma | Malignant | I~II | T2N0M0 |
D10 |  | M | 54 | Larynx | Squamous cell carcinoma | Malignant | I~II | T2N0M0 |
D11 |  | M | 55 | Head and neck, oral cavity | Squamous cell carcinoma | Malignant | I~II | T2N1M0 |
D12 |  | M | 65 | Head and neck, oral cavity | Squamous cell carcinoma | Malignant | I~II | T2N0M0 |
E01 |  | M | 56 | Larynx | Squamous cell carcinoma | Malignant | II | T2N0M0 |
E02 |  | M | 65 | Larynx | Squamous cell carcinoma | Malignant | II | T1N0M0 |
E03 |  | F | 69 | Head and neck, salivary gland | Squamous cell carcinoma | Malignant | II | T1N0M0 |
E04 |  | M | 59 | Epiglottis | Squamous cell carcinoma | Malignant | II~III | T2N0M0 |
E05 |  | M | 55 | Larynx | Squamous cell carcinoma | Malignant | II~III | T2N1M0 |
E06 |  | M | 67 | Larynx | Squamous cell carcinoma | Malignant | II~III | T3N1M0 |
E07 |  | M | 47 | Pharynx | Squamous cell carcinoma | Malignant | II~III | T2N1M0 |
E08 |  | M | 44 | Larynx | Squamous cell carcinoma | Malignant | II~III | T1N1M0 |
E09 |  | M | 62 | Larynx | Squamous cell carcinoma | Malignant | III | T1N1M0 |
E10 |  | M | 64 | Head and neck, oral cavity | Squamous cell carcinoma | Malignant | III | T2N2M0 |
E11 |  | F | 56 | Head and neck, nasopharynx | Squamous cell carcinoma | Malignant | III | T2N0M0 |
E12 |  | M | 64 | Pharynx | Squamous cell carcinoma | Malignant | III | T2N0M0 |
F01 |  | M | 56 | Larynx | Squamous cell carcinoma | Malignant | II | T2N0M0 |
F02 |  | M | 65 | Larynx | Squamous cell carcinoma | Malignant | II | T1N0M0 |
F03 |  | F | 69 | Head and neck, salivary gland | Squamous cell carcinoma | Malignant | II | T1N0M0 |
F04 |  | M | 59 | Epiglottis | Squamous cell carcinoma | Malignant | II~III | T2N0M0 |
F05 |  | M | 55 | Larynx | Squamous cell carcinoma | Malignant | II~III | T2N1M0 |
F06 |  | M | 67 | Larynx | Squamous cell carcinoma | Malignant | II~III | T3N1M0 |
F07 |  | M | 47 | Pharynx | Squamous cell carcinoma | Malignant | II~III | T2N1M0 |
F08 |  | M | 44 | Larynx | Squamous cell carcinoma | Malignant | II~III | T1N1M0 |
F09 |  | M | 62 | Larynx | Squamous cell carcinoma | Malignant | III | T1N1M0 |
F10 |  | M | 64 | Head and neck, oral cavity | Squamous cell carcinoma | Malignant | III | T2N2M0 |
F11 |  | F | 56 | Head and neck, nasopharynx | Squamous cell carcinoma | Malignant | III | T2N0M0 |
F12 |  | M | 64 | Pharynx | Squamous cell carcinoma | Malignant | III | T2N0M0 |
G01 |  | F | 77 | Head and neck, upper lip | Basal cell carcinoma | Malignant | T2N0M0 | |
G02 |  | M | 64 | Head and Neck, left upper mandible | Adenocarcinoma | Malignant | III | T4N0M0 |
G03 |  | F | 57 | Head and neck, salivary gland | Adenoid cystic carcinoma | Malignant | T3N0M0 | |
G04 |  | M | 42 | Head and Neck, left parotid gland | Adenoid cystic carcinoma | Malignant | T3N0M0 | |
G05 |  | F | 35 | Lymph node, neck | Metastatic carcinoma | Malignant | ||
G06 |  | M | 54 | Lymph node, neck | Metastatic squamous cell carcinoma | Malignant | ||
G07 |  | M | 72 | Head and Neck, left neck | Metastatic squamous cell carcinoma | Malignant | ||
G08 |  | M | 27 | Head and neck, salivary gland | Non-Hodgkin T-cell lymphoma? | Malignant | ||
G09 |  | M | 68 | Head and neck, right upper mandible | Non-Hodgkin lymphoma (NK cell?) | Malignant | ||
G10 |  | M | 18 | Scalp | Melanoma | Malignant | ||
G11 |  | F | 77 | Head and neck, nasal cavity | Melanoma | Malignant | ||
G12 |  | M | 33 | Scalp | Dermatofibrosarcoma protuberans | Malignant | ||
H01 |  | F | 77 | Head and neck, upper lip | Basal cell carcinoma | Malignant | T2N0M0 | |
H02 |  | M | 64 | Head and Neck, left upper mandible | Adenocarcinoma | Malignant | III | T4N0M0 |
H03 |  | F | 57 | Head and neck, salivary gland | Adenoid cystic carcinoma | Malignant | T3N0M0 | |
H04 |  | M | 42 | Head and Neck, left parotid gland | Adenoid cystic carcinoma | Malignant | T3N0M0 | |
H05 |  | F | 35 | Lymph node, neck | Metastatic carcinoma | Malignant | ||
H06 |  | M | 54 | Lymph node, neck | Metastatic squamous cell carcinoma | Malignant | ||
H07 |  | M | 72 | Head and Neck, left neck | Metastatic squamous cell carcinoma | Malignant | ||
H08 |  | M | 27 | Head and neck, salivary gland | Non-Hodgkin T-cell lymphoma? | Malignant | ||
H09 |  | M | 68 | Head and neck, right upper mandible | Non-Hodgkin lymphoma (NK cell?) | Malignant | ||
H10 |  | M | 18 | Scalp | Melanoma | Malignant | ||
H11 |  | F | 77 | Head and neck, nasal cavity | Melanoma | Malignant | ||
H12 |  | M | 33 | Scalp | Dermatofibrosarcoma protuberans | Malignant |
bottom of page